1. Home
  2. RFL vs EHGO Comparison

RFL vs EHGO Comparison

Compare RFL & EHGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RFL
  • EHGO
  • Stock Information
  • Founded
  • RFL 2017
  • EHGO 2015
  • Country
  • RFL United States
  • EHGO China
  • Employees
  • RFL N/A
  • EHGO N/A
  • Industry
  • RFL Real Estate
  • EHGO
  • Sector
  • RFL Finance
  • EHGO
  • Exchange
  • RFL Nasdaq
  • EHGO NYSE
  • Market Cap
  • RFL 51.1M
  • EHGO 28.3M
  • IPO Year
  • RFL N/A
  • EHGO 2024
  • Fundamental
  • Price
  • RFL $1.80
  • EHGO $1.08
  • Analyst Decision
  • RFL
  • EHGO
  • Analyst Count
  • RFL 0
  • EHGO 0
  • Target Price
  • RFL N/A
  • EHGO N/A
  • AVG Volume (30 Days)
  • RFL 22.7K
  • EHGO 47.2K
  • Earning Date
  • RFL 03-17-2025
  • EHGO 03-21-2025
  • Dividend Yield
  • RFL N/A
  • EHGO N/A
  • EPS Growth
  • RFL N/A
  • EHGO N/A
  • EPS
  • RFL N/A
  • EHGO 0.00
  • Revenue
  • RFL $697,000.00
  • EHGO $16,963,957.00
  • Revenue This Year
  • RFL N/A
  • EHGO N/A
  • Revenue Next Year
  • RFL N/A
  • EHGO N/A
  • P/E Ratio
  • RFL N/A
  • EHGO $2,931.11
  • Revenue Growth
  • RFL 151.62
  • EHGO N/A
  • 52 Week Low
  • RFL $1.29
  • EHGO $0.91
  • 52 Week High
  • RFL $2.50
  • EHGO $5.50
  • Technical
  • Relative Strength Index (RSI)
  • RFL 36.38
  • EHGO N/A
  • Support Level
  • RFL $1.81
  • EHGO N/A
  • Resistance Level
  • RFL $2.02
  • EHGO N/A
  • Average True Range (ATR)
  • RFL 0.11
  • EHGO 0.00
  • MACD
  • RFL -0.02
  • EHGO 0.00
  • Stochastic Oscillator
  • RFL 6.45
  • EHGO 0.00

About RFL Rafael Holdings Inc. Class B

Rafael Holdings Inc is a holding company with interests in clinical and early-stage pharmaceutical companies. Its primary focus is to expand its investment portfolio through opportunistic investments including therapeutics, which address high unmet medical needs. Through the companies it has invested in, the company is focused on; developing Trappsol Cyclo its clinical program, developing instruments to advance minimally invasive surgeries, preclinical cancer metabolism research operations, and developing pharmaceutical-grade technology Unlokt for third-party cannabis manufacturers. It also holds and manages commercial real estate assets in Jerusalem, Israel. The company's reportable segments are; Infusion Technology, which derives maximum revenue, Healthcare, and Real Estate.

About EHGO ESHALLGO INC

Eshallgo Inc. focuses on two distinct market sectors: office supply sale and leasing, and after-sale maintenance and repair. It is an authorized distributor of brands of office equipment, including HP, Epson, Xerox, Sharp, Toshiba, Konica, Kyocera, and other brands.

Share on Social Networks: